Efficacy and Safety Study of Neu2000KWL for Acute Ischemic Stroke Patients Within 6 Hours of Onset
Status:
Completed
Trial end date:
2019-12-13
Target enrollment:
Participant gender:
Summary
The purpose of the study is to explore safety and efficacy of Salfaprodil administration for
patients with acute ischemic stroke within 6 hours of onset.
Phase:
Phase 2
Details
Lead Sponsor:
Beijing Tiantan Hospital
Collaborators:
Daqing Oil Field Hospital First Affiliated Hospital of Jinan University First Affiliated Hospital of Wenzhou Medical University First Affiliated Hospital of Zhejiang University First Hospital of China Medical University First Hospital of Jilin University General Hospital of Shenyang Military Region Guangzhou First People's Hospital Hebei General Hospital Hebei Medical University Third Hospital Inner Mongolia Baogang Hospital Nanfang Hospital of Southern Medical University Nanjing PLA General Hospital Peking University First Hospital Peking University Third Hospital Qilu Hospital of Shandong University Second Affiliated Hospital of Guangzhou Medical University Second Affiliated Hospital, School of Medicine, Zhejiang University Second Hospital of Shanxi Medical University Shandong Provincial Hospital Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Shanghai Minhang Central Hospital Shanghai Pudong New Area People's Hospital Subei People's Hospital of Jiangsu Province Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University The Central Hospital of Lishui City The First Affiliated Hospital of BaoTou Medical College The First Affiliated Hospital of Soochow University The First Hospital of Jilin University The Second Hospital of Hebei Medical University Tianjin First Central Hospital Tianjin Huanhu Hospital Tongji Hospital Xiangya Hospital of Central South University Xuanwu Hospital, Beijing Zhejiang Apeloa Jiayuan Pharmaceutical Co. Ltd.